Please enter both an email address and a password.

Account login

Need to reset your password?  Enter the email address which you used to register on this site (or your membership/contact number) and we'll email you a link to reset it. You must complete the process within 2hrs of receiving the link.

We've sent you an email

An email has been sent to Simply follow the link provided in the email to reset your password. If you can't find the email please check your junk or spam folder and add to your address book.

NHSBT amber alert and the use of tranexamic acid in surgery

13 Oct 2022

Tuesday 18 October - Additional guidance has now been issued on the use of tranexamic acid in surgery, please see our update.

NHS Blood and Transplant (NHSBT) triggered an ‘amber alert’ on 12 October, meaning hospitals have been asked to put in place management plans to protect blood stocks.

In line with these measures requested by NHSBT, we recommend that use of tranexamic acid is considered in all adult surgical patients and administered if more than 500ml of blood loss is likely. We also recommend that theatre teams consider adding this prompt to the perioperative care theatre checklist process.

Results from the recent POISE-3 clinical trial confirm the quality, safety and cost-effectiveness of using tranexamic acid in moderate surgery, where more than 500ml of blood loss is anticipated. This evidence further supports the NICE quality statement on blood transfusion and complements the recent Centre for Perioperative Care guideline ‘Anaemia in the Perioperative Pathway’.

Increasing the use of tranexamic acid in this way may reduce the risk of cancelling elective surgery due to limited availability of blood stocks.

Please share this with your colleagues, especially those in your perioperative, surgical and anaesthetic departments.

Join our webinar at 6pm on 21 November to hear Professor Neil Mortensen, President of RCS England, and other leading surgeons share important information about the use of Tranexamic acid. The webinar will feature a live Q&A.



Share this page: